Studies from Oregon State University in the Area of Colon Cancer Described (Predictors of Colorectal Cancer Screening Modality Among Newly Age-eligible Medicaid Enrollees)

2021 JAN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Investigators publish new report on Oncology - Colon Cancer. According to news reporting originating in Corvallis, Oregon, by NewsRx journalists, research stated, “This study examines individual- and practice-level predictors of screening modality among 1,484 Medicaid enrollees who initiated colorectal cancer screening (fecal immunochemical test/fecal occult blood tests or colonoscopy) within a year of turning age 50 years. Understanding screening modality patterns for patients and health systems can help optimize colorectal cancer screening initiatives that will lead to high screening completion rates.”

Financial supporters for this research include Knight Cancer Institute at Oregon Health & Science University, Oregon State University Cancer Prevention and Control Initiative, Cancer Prevention, Control, Behavioral Sciences, and Populations Sciences Career Development Award from the National Cancer Institute, Kaiser Permanente Northwest Center for Health Research (KPCHR), European Union (EU), Quidel Corporation.

The news reporters obtained a quote from the research from Oregon State University, “Multivariable logistic regression was conducted in 2019 to analyze Medicaid claims data (January 2013-June 2015) to explore predictors of colonoscopy screening (versus fecal testing). Overall, 64% of enrollees received a colonoscopy and 36% received a fecal immunochemical test/fecal occult blood test. Male (OR=1.21, 95% CI=1.08, 1.37) compared with female enrollees and those with 4-6 (OR=1.57, 95% CI=1.15, 2.15), 7-10 (OR=2.23, 95% CI=1.64, 3.03), and >11 (OR=1.79, 95% CI=1.22, 2.65) primary care visits compared with 0-3 visits had higher odds of colonoscopy screening. Non-White, non-Hispanic enrollees (OR=0.71, 95% CI=0.58, 0.87) compared with White, non-Hispanics Whites had lower odds of colonoscopy screening. Practices with an endoscopy facility within their ZIP code (OR=1.50, 95% CI=1.08, 2.08) compared with practices without a nearby endoscopy facility had higher odds of colonoscopy screening. Among newly age-eligible Medicaid enrollees who received colorectal cancer screening, non-White, non-Hispanic individuals were less likely and male enrollees and those with >4 primary care visits were more likely to undergo colonoscopy versus fecal immunochemical test/fecal occult blood test. Colonoscopy also was the more common modality among adults whose primary care clinic had an endoscopy facility in the same ZIP code.”

According to the news reporters, the research concluded: “Future research is needed to fully understand patient, provider, and practice preferences regarding screening modality.”

This research has been peer-reviewed.

For more information on this research see: Predictors of Colorectal Cancer Screening Modality Among Newly Age-eligible Medicaid Enrollees. American Journal of Preventive Medicine, 2021;60(1):72-79. American Journal of Preventive Medicine can be contacted at: Elsevier, Ste 800, 230 Park Ave, New York, NY 10169, USA. (Elsevier - www.elsevier.com; American Journal of Preventive Medicine - http://www.journals.elsevier.com/american-journal-of-preventive-medicine/)

Our news correspondents report that additional information may be obtained by contacting Cynthia M. Mojica, Oregon State University, College of Public Health and Human Sciences, 2250 Southwest Jef Ferson Way, Waldo 445, Corvallis, OR 97331, United States. Additional authors for this research include Bonnie Lind, Yifan Gu, Gloria D. Coronado and Melinda M. Davis.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.amepre.2020.08.003. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)